Literature DB >> 11556847

Cell surface antigens in renal tumour cells: detection by immunoluminescence and enzymatic analysis.

F Laube1, B Göhring, H Sann, I Willhardt.   

Abstract

Two renal cell carcinoma cell lines (49RC 43STR and 75RC 2STR) were characterized by detection of the cell surface proteins: CD44(var), intercellular adhesion molecule-1 (ICAM-1), urokinase-type plasminogen activator (uPA) and its receptor and aminopeptidase N (APN). To detect their localization the immunoluminescent technique was used. In addition, the enzyme activity of uPA and APN was investigated in cell suspensions as well as in monolayers. The latter procedure was more advantageous since the additional use of HPLC permits a single registration of the fluorescent hydrolysis-product AMC (7-amino-4-methylcoumarin) without interference by cellular autofluorescence or non-reacted fluorescent substrate. Unlike 75RC 2STR, the cell line 49RC 43STR expressed high levels of uPA and APN. Contrary to that the cell line 75RC 2STR expressed high levels of ICAM-1 and CD44(v6), whereas 49RC 43STR showed a low level of ICAM-1 and no distinct light signal with anti-CD44(v6). The uPA activity was measured directly as well as indirectly (via plasmin) with the substrate Z-Gly-Gly-Arg-AMC. Both activator and plasmin activity were inhibited by D-Val-Phe-Lys-CMK and phenylmethylsulfonyl fluoride. The anti-catalytic antibody to uPA and that to uPA receptor were found to be inhibiting the uPA activity in a concentration-dependent manner. APN activity was assayed using alanine-p-nitroanilide. Peptidase activity was effectively inhibited by 1,10-phenanthroline and partly inhibited by ethylenediamine-tetraacetic acid. Copyright 2001 Cancer Research Campaign http://www.bjcancer.com.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11556847      PMCID: PMC2375078          DOI: 10.1054/bjoc.2001.2004

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  28 in total

1.  Direct fluorescent assay of urokinase and plasminogen activators of normal and malignant cells: kinetics and inhibitor profiles.

Authors:  M Zimmerman; J P Quigley; B Ashe; C Dorn; R Goldfarb; W Troll
Journal:  Proc Natl Acad Sci U S A       Date:  1978-02       Impact factor: 11.205

2.  Modulation of in vitro invasion of human glioblastoma cells by urokinase-type plasminogen activator receptor antibody.

Authors:  S Mohanam; R Sawaya; I McCutcheon; F Ali-Osman; D Boyd; J S Rao
Journal:  Cancer Res       Date:  1993-09-15       Impact factor: 12.701

3.  Stimulation of intercellular adhesion molecule-1 (ICAM-1) antigen expression and shedding by interferon-gamma and phorbol ester in human renal carcinoma cell cultures: relation to peripheral blood mononuclear cell adhesion.

Authors:  A B Hansen; S T Lillevang; C B Andersen
Journal:  Urol Res       Date:  1994

4.  Generation of cell surface-bound plasmin by cell-associated urokinase-type or secreted tissue-type plasminogen activator: a key event in melanoma cell invasiveness in vitro.

Authors:  A Meissauer; M D Kramer; V Schirrmacher; G Brunner
Journal:  Exp Cell Res       Date:  1992-04       Impact factor: 3.905

5.  Endopeptidase 24.11/CD10 is down-regulated in renal cell cancer.

Authors:  B Göhring; H J Holzhausen; A Meye; H Heynemann; U Rebmann; J Langner; D Riemann
Journal:  Int J Mol Med       Date:  1998-10       Impact factor: 4.101

6.  Release of GPI-anchored membrane aminopeptidase P by enzymes and detergents has some peculiarities.

Authors:  R Koelsch; S Gottwald; J Lasch
Journal:  Biochim Biophys Acta       Date:  1994-02-23

7.  Stimulation of the expression and the enzyme activity of aminopeptidase N/CD13 and dipeptidylpeptidase IV/CD26 on human renal cell carcinoma cells and renal tubular epithelial cells by T cell-derived cytokines, such as IL-4 and IL-13.

Authors:  D Riemann; A Kehlen; J Langner
Journal:  Clin Exp Immunol       Date:  1995-05       Impact factor: 4.330

8.  Receptor-mediated internalization and degradation of urokinase is caused by its specific inhibitor PAI-1.

Authors:  M V Cubellis; T C Wun; F Blasi
Journal:  EMBO J       Date:  1990-04       Impact factor: 11.598

9.  The urokinase-type plasminogen activator receptor, a GPI-linked protein, is localized in caveolae.

Authors:  A Stahl; B M Mueller
Journal:  J Cell Biol       Date:  1995-04       Impact factor: 10.539

10.  Role of aminopeptidase N (CD13) in tumor-cell invasion and extracellular matrix degradation.

Authors:  I Saiki; H Fujii; J Yoneda; F Abe; M Nakajima; T Tsuruo; I Azuma
Journal:  Int J Cancer       Date:  1993-04-22       Impact factor: 7.396

View more
  2 in total

1.  An amine-derivatized, DOTA-loaded polymeric support for Fmoc Solid Phase Peptide Synthesis.

Authors:  Byunghee Yoo; Vipul R Sheth; Mark D Pagel
Journal:  Tetrahedron Lett       Date:  2009-08-05       Impact factor: 2.415

2.  Detection of in vivo enzyme activity with CatalyCEST MRI.

Authors:  Byunghee Yoo; Vipul R Sheth; Christine M Howison; Matthew J K Douglas; Carlos T Pineda; Erin A Maine; Amanda F Baker; Mark D Pagel
Journal:  Magn Reson Med       Date:  2014-03       Impact factor: 4.668

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.